Ani Khroyan OD in Glendale, California

Home California Glendale

Ani Khroyan OD has Optometry as her primary medical specialty. Their primary office is: 413 E Glenoaks Blvd in Glendale, California. They attended Southern California College Of Optometry and graduated in 2005 (around 19 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ani Khroyan OD Office Phone and Directions

Ani Khroyan OD
413 E Glenoaks Blvd
Glendale, California 91207
818-230-0550

Patient Ratings
Please rate your experience with Ani Khroyan OD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 818-230-0550

Enter a starting address:

Healthcare Info for Ani Khroyan OD

Medical School: Southern California College Of Optometry
Graduation Year: 2005
The Primary Medical Specialty for Ani Khroyan OD is listed as: Optometry
Credentials: OD
Additional Credentials:
Approximate Years of Experience: 19
PAC (PECOS ID)#: 9234167164
NPI #: 1669584702
NPI Created On: 08/31/2006
NPI Last Updated Listed as: 04/27/2015
Primary Taxonomy Code: 152W00000X
License Number:
12807 TPA
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Not Assigned.

Services and Procedures include:

Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
Photography of the retina

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $150

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 853773935

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Ophthalmic Surgery

Name of Drug #1: Hydrus Microstent